Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EOG | Common Stock | +Grant/Award | $0 | +6,273 | +9.72% | $0.00 | 70,789 | Sep 27, 2021 | Direct | |
transaction | EOG | Common Stock | -Tax liability | -$47,041 | -575 | -0.81% | $81.81 | 70,214 | Sep 27, 2021 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EOG | Stock Appreciation Rights | +Grant/Award | $0 | +9,365 | $0.00 | 9,365 | Sep 27, 2021 | Common Stock | 9,365 | $81.81 | Direct | F2 |
Id | Content |
---|---|
F1 | Relates to the vesting of 2,360 restricted shares on September 27, 2021. |
F2 | The SARs granted will become exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 27, 2021 date of grant. The SARs will become fully exercisable on September 27, 2024. |